Cubist Systematic Strategies’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.41M Sell
93,791
-564,564
-86% -$8.22M 0.01% 1770
2025
Q2
$9.29M Buy
+658,355
New +$11.7M 0.04% 650
2025
Q1
Sell
-23,671
Closed -$884K 2871
2024
Q4
$884K Buy
+23,671
New +$1.1M 0.01% 1869
2024
Q3
Sell
-97,902
Closed -$3.4M 2999
2024
Q2
$3.4M Buy
+97,902
New +$3.87M 0.02% 1008
2024
Q1
Sell
-69,255
Closed -$2.96M 3728
2023
Q4
$2.96M Buy
+69,255
New +$2.15M 0.02% 1203
2023
Q2
Sell
-1,107
Closed -$15.1K 3528
2023
Q1
$15.1K Buy
1,107
+568
+105% +$9.04K ﹤0.01% 3692
2022
Q4
$7.48K Buy
+539
New +$7.61K ﹤0.01% 4063

Other funds holding BHVN

Cubist Systematic Strategies's BHVN Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Biohaven (BHVN) stake by 86% in Q3 2025, selling an estimated $8.22M and leaving 93,791 shares worth $1.41M. The position accounts for 0.01% of the portfolio, ranked #1770.

Cubist Systematic Strategies first reported a position in BHVN in Q4 2022 and has held it in 7 quarters since. The position peaked at $9.29M in Q2 2025. 264 funds tracked by Wall St. Rank hold BHVN as of Q3 2025.

  • Cubist Systematic Strategies held 93,791 shares of Biohaven worth $1.41M as of Q3 2025.
  • Cubist Systematic Strategies sold 564,564 Biohaven shares in Q3 2025, an estimated $8.22M.
  • Biohaven made up 0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1770 holding.
  • Cubist Systematic Strategies first reported a position in Biohaven in Q4 2022 and has held it in 7 quarters since.
  • Cubist Systematic Strategies's Biohaven position peaked at $9.29M in Q2 2025.
  • 264 funds tracked by Wall St. Rank held Biohaven as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.